Recruiting Geographic Atrophy Studies in Porto Alegre
Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
This is a phase 1/2, multicenter, open-label umbrella platform study that will evaluate the safety and tolerability of sacituzumab tirumotecan with pembrolizumab and fluoropyrimidine chemotherapy for ...
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
This is a phase 1/2 multicenter, open-label umbrella platform study that will evaluate the safety and efficacy of sacituzumab tirumotecan (MK-2870) plus paclitaxel versus ramucirumab plus paclitaxel, ...
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late-infantile and juvenile forms of GM1 gan...
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
Study J3Z-MC-OJAE is a Phase 1/2, multicenter, open-label, dose-finding study of LY3884961 evaluating the safety and tolerability in adults with peripheral manifestations of GD. Up to 3 dose levels o...
About Geographic Atrophy Clinical Trials in Porto Alegre
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 4 geographic atrophy clinical trials recruiting participants in Porto Alegre, RIO%20GRANDE%20DO%20SUL. These studies are seeking a combined 310 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Azafaros A.G., Prevail Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Porto Alegre — FAQ
Are there geographic atrophy clinical trials in Porto Alegre?
Yes, there are 4 geographic atrophy clinical trials currently recruiting in Porto Alegre, RIO%20GRANDE%20DO%20SUL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Porto Alegre?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Porto Alegre research site will contact you about next steps.
Are clinical trials in Porto Alegre free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Porto Alegre studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 4 active trials in Porto Alegre are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated March 2, 2026 from ClinicalTrials.gov